[Skip to Content]
[Skip to Content Landing]
September 20, 1902


JAMA. 1902;XXXIX(12):706-707. doi:10.1001/jama.1902.02480380042012

Whatever promises to be even a palliative in the treatment of cancer is worthy of the attention of the therapeutist. Especially is this the case if the agency or procedure is along the lines that have been successfully followed in other disorders, though as yet untried or unsuccessful in the management of malignant growths. The suggestion of serotherapy of cancer is a very natural one, but hitherto nothing really encouraging has resulted from experiment. Jensen, it is true, had noticed modification in cancer growth in mice, shriveling and suppuration of the tumor following serum injections from cancer tissue, but nothing that seemed significant enough to warrant any strong expectations of good results in actual therapeutics. Very recently, however, Von Leyden and Blumenthal have carried their research further and report1 actual beneficial effects on human patients. They first experimented on cancerous dogs, using serum expressed from other cancerous growths on